A Phase I, Single Center, Blinded, Controlled Study Evaluating Safety, Tolerability and Pharmacokinetic Profile of Levodopa Following Repeated Administration of Oral Levodopa/Carbidopa and Continuously Delivered ND0611.
Phase of Trial: Phase I
Latest Information Update: 03 Oct 2010
At a glance
- Drugs Carbidopa (Primary) ; Levodopa/carbidopa
- Indications Parkinson's disease
- Focus Adverse reactions; Pharmacokinetics
- Sponsors NeuroDerm
- 03 Oct 2010 Actual initiation date (Apr 2010) added as reported by ClinicalTrials.gov.
- 03 Oct 2010 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
- 03 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.